Abstract:Rickettsiosis includes a diversity of culture-negative non-specific systemic infections. Laboratory diagnosis of rickettsiosis is often not easy. In this 12-month study, six patients with a variety of rickettsia infections of the spotted fever group, typhus group and scrub typhus were diagnosed directly or indirectly by metagenomic next-generation sequencing (mNGS). The patient with Japanese spotted fever was rapidly made when mNGS analysis of the patient's blood revealed Rickettsia japonica sequences. For the two patients with Rickettsia felis chest infections, the bacterium was detected in the bronchoalveolar lavage of one case and lung biopsy of the other. Both patients had underlying malignancies, carcinoma of the breast and carcinoma of the lung respectively, and were on chemotherapy with immunosuppressive effect. For the remaining three patients who presented over a period of 13 weeks, all had fever, headache and the typical eschar. They also had increased serum transaminases and responded promptly to doxycycline. However, the Weil-Felix test results of all three patients were negative. Since we considered the three cases typical of rickettsiosis, we submitted their serum samples for mNGS analysis. Results showed that Orientia tsutsugamushi sequences were present in the serum of one case. In view of the positive mNGS results, we repeated the Weil-Felix test for the residual sera of all three patients and it revealed that those of the other two cases showed OX-19 titers of 1:640 and 1:160 respectively, inferring that these two patients probably had rickettsiosis of the typhus group. As for the patient positive for O . tsutsugamushi sequences, we also detected IgM for O . tsutsugamushi in the serum, which double confirmed that it was a case of scrub typhus. mNGS is an important molecular tool and can complement serology for laboratory diagnosis of rickettsiosis. Rickettsiosis includes a diversity of systemic infections presented with non-specific symptoms. Laboratory diagnosis of rickettsiosis is often not easy. In this 12-month study, six patients with a variety of rickettsia infections were diagnosed directly or indirectly by metagenomic next-generation sequencing (mNGS). These include one patient with Japanese spotted fever in whom Rickettsia japonica sequences were detected in blood, two patients with Rickettsia felis chest infections in whom R . felis sequences were detected in respiratory samples, one patient with scrub typhus in whom Orientia tsutsugamushi sequences were detected in serum, and two patients with rickettsiosis of the typhus group. In particular, the last three patients had initial false-negative Weil-Felix test results performed in a central reference laboratory but the diagnosis of rickettsiosis was subsequently confirmed by mNGS and repeated serology. mNGS is an important diagnostic tool for rickettsiosis and other difficult-to-diagnose systemic infections.

A proof of concept for a targeted enrichment approach to the simultaneous detection and characterization of rickettsial pathogens from clinical specimens

Empirical assessment of the enrichment-based metagenomic methods in identifying diverse respiratory pathogens

Targeted sequencing of Enterobacterales bacteria using CRISPR-Cas9 enrichment and Oxford Nanopore Technologies

Comparison of an automated DNA extraction and 16S rDNA real time PCR/sequencing diagnostic method using optimized reagents with culture during a 15-month study using specimens from sterile body sites

Pathogen screening based on a combination of rDNA targeted sequencing and shotgun sequencing

[Simultaneous detection of 7 important Rickettsiales pathogens by TaqMan-probe quantitative real-time PCR]

Clinical PathoScope: rapid alignment and filtration for accurate pathogen identification in clinical samples using unassembled sequencing data

Target enrichment improves culture-independent detection of Neisseria gonorrhoeae and antimicrobial resistance determinants direct from clinical samples with Nanopore sequencing

Usefulness of next-generation sequencing for laboratory diagnosis of rickettsiosis

Target enrichment improves culture-independent detection of direct from sample with Nanopore sequencing

Sensitive Identification of Bacterial DNA in Clinical Specimens by Broad-Range 16S rRNA Gene Enrichment

An integrated method for targeted Oxford Nanopore sequencing and automated bioinformatics for the simultaneous detection of bacteria, fungi, and ARG

Highly efficient enrichment and identification of pathogens using a herringbone microfluidic chip and by MALDI-TOF mass spectrometry

Mass Spectrometry Proteotyping-Based Detection and Identification of Staphylococcus aureus, Escherichia coli, and Candida albicans in Blood

Development and proof-of-concept demonstration of a clinical metagenomics method for the rapid detection of bloodstream infection

Detection of Tick-Borne Bacteria from Whole Blood Using 16S Ribosomal RNA Gene PCR Followed by Next-Generation Sequencing

An expanded genetic toolkit for inducible expression and targeted gene silencing in Rickettsia parkeri

Development and Optimization of an Unbiased, Metagenomics-Based Pathogen Detection Workflow for Infectious Disease and Biosurveillance Applications

Portable In-Field DNA Sequencing for Rapid Detection of Pathogens and Antimicrobial Resistance: A Proof-of-Concept Study

Development and validation of a novel detection method for Rickettsia rickettsii using a loop-mediated isothermal amplification assay

Unified metagenomic method for rapid detection of microorganisms in clinical samples